KI-Beratung Beta

Produktbild: Clinical Ophthalmic Oncology

Clinical Ophthalmic Oncology Retinoblastoma

Fr. 160.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Written by internationally renowned experts, the 3rd edition of this six volume textbook provides detailed practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. Supplying the reader with state-of-the-art knowledge required in order to identify these cancers...

Beschreibung

Written by internationally renowned experts, the 3rd edition of this six volume textbook provides detailed practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. Supplying the reader with state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible, this book is divided into six volumes: Basic Principles, Eyelid and Conjunctival Tumors, Orbital Tumors, Uveal Tumors, Retinal Tumors, and Retinoblastoma. The information presented enables readers to provide effective patient care using the latest knowledge on ophthalmic oncology and to verify diagnostic conclusions based on comparison with numerous full-color clinical photographs from the authors' private collections, histopathologic microphotographs, imaging studies, and crisp illustrations. 

Clinical Ophthalmic Oncology's clinically focused and user-friendly format allows for rapid retrieval of information in daily practice and is written for residents, fellows, and any physician involved in the care of patients with ocular or orbital malignancies. Additionally, this edition adds several hundred new images to improve comprehension of procedures and techniques. This volume describes the classification, differential diagnosis, and imaging of retinoblastoma and discusses the most suitable treatment options for different tumor types.


   

Portrait

Jesse L. Berry, MD, received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center and then completed a fellowship in Ocular Oncology at Children’s Hospital Los Angeles. Dr. Berry is the founder of WOO, Women in Ocular Oncology.

Jonathan Kim, MD, is Director of the Retinoblastoma Program, Attending Physician, and Associate Professor of Clinical Surgery at the Keck School of Medicine of USC. Dr. Kim provides clinical expertise in the management of pediatric intraocular tumors. He was trained at Memorial Sloan-Kettering Cancer Center, Jules Stein Eye Institute at UCLA, and the Massachusetts Eye and Ear Infirmary at Harvard Medical School. He is developing new treatment modalities to save the eyes of children with retinoblastoma and is actively engaged in new research projects. 

Bertil Damato, MD, PhD, is Professor of Ophthalmology and Radiation Oncology and Director of the Ocular Oncology Service at the University of California, San Francisco. Until 2013, he was Consultant Ophthalmologist at the Royal Liverpool University Hospital, where he was Director of the Ocular Oncology Service, which he established in 1993. Dr. Damato has published more than 200 peer-reviewed articles, 68 reviews, 75 book chapters and 6 books, one as single author.
Arun Singh, MD, is Director of the Cole Eye Institute at Cleveland Clinic in the Department of Ophthalmic Oncology. He is also the Series Editor for Springer's Essentials in Ophthalmology series and was the former Editor for The British Journal of Ophthalmology and is the current Editor of Ocular Oncology and Pathology. 


Jesse L. Berry, MD

Assistant Professor of Clinical Ophthalmology

USC RoskiEye Institute

Children's Hospital Los Angeles  

Keck School of Medicine of USC

1975 Zonal Ave, Los Angeles

California, USA

 

Jonathan W. Kim, MD

Director of Retinoblastoma Program, Children's Hospital Los Angeles

Associate Professor of Clinical Ophthalmology

Department of Ophthalmology 

USC Roski Eye Institute

Keck School of Medicine of USC

1975 Zonal Ave, Los Angeles

California, USA

Bertil E. Damato, MD, PhD

Professor of Ophthalmology and Radiation Oncology

University of Oxford

Nuffield Department of Clinical Neurosciences

John Radcliffe Hospital

Oxford, UK

Arun D. Singh, MD

Professor of Ophthalmology

Editor, Ocular Oncology and Pathology

Director, Dept. of Ophthalmic Oncology

Cole Eye Institute, Cleveland Clinic

9500 Euclid Avenue, Cleveland

Ohio, USA

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

07.05.2019

Herausgeber Jesse L. Berry + weitere
Verlag Springer

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

07.05.2019

Herausgeber
Verlag Springer
Seitenzahl

303

Maße (L/B/H)

26/18.3/1.9 cm

Gewicht

864 g

Auflage

3. Auflage

Sprache

Englisch

ISBN

978-3-030-11122-9

Herstelleradresse

Springer International Publishing AG
Gewerbestr. 11
6330 Cham
Schweiz
Url: www.springer.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Clinical Ophthalmic Oncology
  • Retinoblastoma: Evaluation and Diagnosis

    Differential Diagnosis of Leukocoria

    Retinoblastoma: Staging and Grouping

    Retinoblastoma: Incidence and Etiologic Factors                             

    Retinoblastoma: An International Perspective

    Retinoblastoma Tumorigenesis

    Animal Models in Retinoblastoma Research

    Retinocytoma or Retinoma

    Retinoblastoma: Genetic Counseling and Testing

    Retinoblastoma: Treatment Options

    Retinoblastoma: Focal Therapy – Laser Treatment and Cryotherapy

    Retinoblastoma: Focal Therapies: Brachytherapy

    Retinoblastoma: Intravenous Chemotherapy

    Intra-ophthalmic Artery Chemotherapy for Retinoblastoma

    Retinoblastoma: Intravitreal chemotherapy

    Retinoblastoma: External beam radiation

    Retinoblastoma: Enucleation

    Retinoblastoma: Evolving Therapies

    Histopathologic Features and Prognostic Factors

    Orbital Retinoblastoma: Diagnosis and Management

    Retinoblastoma: Metastatic Disease

    Non ocular tumors and other long term complications

    Trilateral Retinoblastoma

    Screening Children at Risk for Retinoblastoma

    Children’s Oncology Group (COG) Trials for Retinoblastoma

    Social Aspects, Advocacy and Organizations

                

    Retinoblastoma: Metastatic Disease

    Non-ocular Tumors

    Trilateral Retinoblastoma

    Children’s Oncology Group (COG) Trials for Retinoblastoma